| Product Code: ETC5306080 | Publication Date: Nov 2023 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
During 2020-2024, the Iceland pneumonia vaccine market witnessed a steady increase in imports. The compound annual growth rate (CAGR) from 2020 to 2024 was 24.12%. Specifically, in 2023-2024, the year-on-year growth rate was 14.25%, contributing to the overall rise in import volumes during this period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iceland Pneumonia Vaccine Market Overview |
3.1 Iceland Country Macro Economic Indicators |
3.2 Iceland Pneumonia Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Iceland Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Iceland Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Iceland Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2022 & 2032F |
3.6 Iceland Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.7 Iceland Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2022 & 2032F |
3.8 Iceland Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Iceland Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumonia |
4.2.2 Growing elderly population in Iceland, who are at higher risk of contracting pneumonia |
4.2.3 Government initiatives and healthcare policies promoting vaccination programs |
4.3 Market Restraints |
4.3.1 High cost associated with developing and manufacturing pneumonia vaccines |
4.3.2 Limited accessibility of vaccines in remote areas of Iceland |
4.3.3 Potential side effects and safety concerns related to pneumonia vaccines |
5 Iceland Pneumonia Vaccine Market Trends |
6 Iceland Pneumonia Vaccine Market Segmentations |
6.1 Iceland Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Iceland Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2022-2032F |
6.1.3 Iceland Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2022-2032F |
6.2 Iceland Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Iceland Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2022-2032F |
6.2.3 Iceland Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2022-2032F |
6.2.4 Iceland Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2022-2032F |
6.3 Iceland Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Iceland Pneumonia Vaccine Market Revenues & Volume, By Public, 2022-2032F |
6.3.3 Iceland Pneumonia Vaccine Market Revenues & Volume, By Private, 2022-2032F |
6.4 Iceland Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Iceland Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2022-2032F |
6.4.3 Iceland Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2022-2032F |
6.4.4 Iceland Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2022-2032F |
7 Iceland Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Iceland Pneumonia Vaccine Market Export to Major Countries |
7.2 Iceland Pneumonia Vaccine Market Imports from Major Countries |
8 Iceland Pneumonia Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate among the elderly population in Iceland |
8.2 Number of pneumonia cases reported annually in Iceland |
8.3 Rate of pneumonia-related hospitalizations in Iceland |
9 Iceland Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Iceland Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2022 & 2032F |
9.2 Iceland Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.3 Iceland Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2022 & 2032F |
9.4 Iceland Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Iceland Pneumonia Vaccine Market - Competitive Landscape |
10.1 Iceland Pneumonia Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Iceland Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here